Skip to main content

Table 2 Overview of measures

From: Effectiveness of blended depression treatment for adults in specialised mental healthcare: study protocol for a randomised controlled trial

Variable

Instrument

T0*

T1*

T2*

T3*

Measures taken from patient

Demographics (patient characteristics)

 

X

   

Current and history of treatment

 

X

   

Diagnosis of depression and comorbid disorders

M.I.N.I. 5.0

X

  

X

Depressive symptoms

PHQ-9

X

X

X

X

Depressive symptoms & severity

QIDS-SR-16

X

X

X

X

Health related well-being (QALY)

EQ-5D-5L

X

X

X

X

Health care uptake and productivity losses TIC-P

TIC-P

X

X

X

X

Sense of mastery

SOMS

X

X

X

X

Treatment preference

 

X

   

Patient expectancy

CEQ

X

   

Therapeutic alliance

WAI-SF-PT

 

X

  

Technology alliance

WAI-Online Therapya

 

X

  

Client satisfaction with treatment

CSQ-8

 

X

  

Satisfaction with the online program SUS

SUSa

 

X

  

Possible negative side-effects

INEP

  

X

 

Measures taken from therapist

Therapeutic alliance

WAI-SF-THb

 

X

  

Satisfaction with the online program

SUSc

 

X

  
  1. aOffered to condition receiving blended treatment only
  2. bHas to be completed for each patient. Offered at the same time point as T1 assessment of the patient
  3. cHas to be completed once per therapist after completion of the first blended treatment
  4. *T0 refers to baseline and T1, T2 and T3 to the 3, 6 and 12 month questionnaires